Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment

    • 12:00 - 13:00
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Locally Advanced Non-small Cell Lung Cancer
    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      Session Moderator

      12:00 - 12:00  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      OA02.01 - Session Introduction

      12:00 - 12:01  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      OA02.02 - Session Introduction

      12:01 - 12:02  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      OA02.03 - Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial

      12:02 - 12:12  |  Presenter: Marta Casarrubios

      • Abstract

      Loading...

    • +

      OA02.04 - Multimodal Management of T4 N2 Non-small-cell Lung Cancer with Additional Ipsilateral Pulmonary Nodules

      12:12 - 12:22  |  Presenter: Arvind Kumar

      • Abstract

      Loading...

    • +

      OA02.05 - Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study

      12:22 - 12:32  |  Presenter: Yi-Long Wu

      • Abstract

      Loading...

    • +

      OA02.06 - Discussant

      12:32 - 12:42  |  Presenter: Linda Martin

      • Abstract

      Loading...

    • +

      OA02.07 - Live Q&A

      12:42 - 13:00

      • Abstract

      Loading...

  • +

    OA03 - Molecular Targeted Treatments

    • 14:30 - 15:40
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      OA03.04 - Phase I A Study to Evaluate GDC-6036 Monotherapy in Patients with Non-small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation

      14:42 - 14:52  |  Presenter: Adrian Sacher

      • Abstract

      Loading...

  • +

    MA05 - Immune Landscape and Molecular Profiling of Lung Cancer

    • 15:45 - 16:45
    • 8/07/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Tumor Biology and Biomarkers
    • +

      Session Moderator

      15:45 - 15:45  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      Session Moderator

      15:45 - 15:45  |  Presenter: Tina Cascone

      • Abstract

      Loading...

    • +

      MA05.01 - Session Introduction

      15:45 - 15:46  |  Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      MA05.02 - Session Introduction

      15:46 - 15:47  |  Presenter: Tina Cascone

      • Abstract

      Loading...

    • +

      MA05.03 - Utilization of Genomic Mutation Signature to Predict the Immunotherapy Response in Non-small Cell Lung Cancer

      15:47 - 15:52  |  Presenter: Wenbin Li

      • Abstract

      Loading...

    • +

      MA05.04 - Multiplex Phenotyping Reveals Spatial Immune Patterns in NSCLC

      15:52 - 15:57  |  Presenter: Max Wilhelm Backman

      • Abstract

      Loading...

    • +

      MA05.05 - Analysis of CREBBP as a Potential Biomarker for Immune Checkpoint Therapy in Solid Tumors and Its Correlation With Immune Microenvironment

      15:57 - 16:02  |  Presenter: Xiaoli Liu

      • Abstract

      Loading...

    • +

      MA05.06 - Discussant

      16:02 - 16:12  |  Presenter: Fabio Pagni

      • Abstract

      Loading...

    • +

      MA05.07 - Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer With MET Exon 14 Skipping

      15:57 - 16:02  |  Presenter: Yuchen Han

      • Abstract

      Loading...

    • +

      MA05.08 - MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History

      16:17 - 16:22  |  Presenter: Jennifer A. Marks

      • Abstract

      Loading...

    • +

      MA05.09 - Genomic Mapping of Metastatic Organotropism: Analysis of 2326 Primary and Organ-Specific Metastases in Lung Adenocarcinoma

      16:22 - 16:27  |  Presenter: Harry Lengel

      • Abstract

      Loading...

    • +

      MA05.10 - Discussant

      16:27 - 16:37  |  Presenter: Giulia Pasello

      • Abstract

      Loading...

    • +

      MA05.11 - Live Q&A

      16:37 - 16:45

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      EP08.01-029 - NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases

      Presenter: Ernest Nadal

      • Abstract

      Loading...

  • +

    EP14.01 - Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Small Cell Lung Cancer and Neuro-endocrine Tumors - Informing ES-SCLC
    • +

      EP14.01-015 - IMforte: A Phase III Study of Lurbinectedin and Atezolizumab Versus Atezolizumab as Maintenance Therapy in ES-SCLC

      Presenter: Luis Paz-Ares

      • Abstract

      Loading...

    • +

      EP14.01-020 - Trial in Progress: [177Lu]Lu-DOTA-TATE Combination Therapy in Treatment-Naïve Extensive Stage Small Cell Lung Cancer

      Presenter: Stephen V. Liu

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity

      Presenter: Francesco Passiglia

      • Abstract

      Loading...

  • +

    P1.16 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 17:00 - 19:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      P1.16-04 - Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors

      Presenter: Niels Reinmuth

      • Abstract

      Loading...

  • +

    OA12 - Novel and Combination Strategies for SCLC

    • 16:00 - 17:00
    • 8/08/2022
    • Location: Hall C8
    • Not for CME Credit
    • Type: Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      OA12.05 - Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer

      16:22 - 16:32  |  Presenter: Hossein Borghaei

      • Abstract

      Loading...

  • +

    P2.07 - Pathology - Tumour Genomics

    • 17:15 - 19:15
    • 8/08/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: Regular Poster
    • Track: Pathology - Tumour Genomics
    • +

      P2.07-02 - RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC

      Presenter: Susana Hernandez

      • Abstract

      Loading...

  • +

    MA13 - Update on ROS1 Inhibitors and New Pathways

    • 12:00 - 13:00
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      MA13.07 - TROPION-Lung02: Initial Results for Datopotamab Deruxtecan Plus Pembrolizumab and Platinum Chemotherapy in Advanced NSCLC

      12:27 - 12:32  |  Presenter: Benjamin Levy

      • Abstract

      Loading...